Cargando…
Targeting of protease activator receptor-2 (PAR-2) antagonist FSLLRY-NH2 as an asthma adjuvant therapy
Asthma is a chronic inflammatory and multifactorial respiratory tract disease. It affects over 18 million adults and 6 million children in the USA with Puerto Ricans showing the highest prevalence (12%–19%). This airways illness can be triggered by an environmental stimulus such as grass pollen, fun...
Autores principales: | Ocasio-Rivera, Marinel, Marin-Maldonado, Frances, Trossi-Torres, Geraline, Ortiz-Rosado, Angely, Rodríguez-Irizarry, Valerie, Rodriguez-Lopez, Eric, Martínez, Sahayra, Almodóvar, Sharilyn, Suarez-Martínez, Edu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581070/ https://www.ncbi.nlm.nih.gov/pubmed/33120736 http://dx.doi.org/10.1097/MD.0000000000022351 |
Ejemplares similares
-
Association Between NAT2 Polymorphisms and Lung Cancer Susceptibility
por: Liu, Chang, et al.
Publicado: (2015) -
Two cases of Dieulafoy lesions of the bronchus with novel comorbid associations and endobronchial ablative management
por: Sheth, Hardik S., et al.
Publicado: (2018) -
Association of polymorphisms in TLR2 and TLR4 with asthma risk: An update meta-analysis
por: Zhao, Junling, et al.
Publicado: (2017) -
Combined clinical and imaging features better predict the critical outcomes of patients with SARS-COV-2
por: Yue, Ting, et al.
Publicado: (2021) -
Nebulized enriched heparin to treat no critical patients with Sars-Cov-2: Triple-blind clinical trial
por: Bertanha, Matheus, et al.
Publicado: (2021)